What are the differential diagnoses and recommended treatments for a rash limited to the palms?

Differential Diagnoses for Palmar Rashes

For rashes limited to the palms, the most critical diagnoses to consider are Rocky Mountain Spotted Fever (RMSF), palmoplantar psoriasis, contact dermatitis (allergic and irritant), and palmoplantar pustulosis, with RMSF requiring immediate recognition due to its 5-10% mortality rate. 1

Life-Threatening Conditions to Rule Out First

Rocky Mountain Spotted Fever

• Classic presentation includes maculopapular rash spreading to palms and soles by day 5-6 of illness, accompanied by fever, headache, and myalgia 1
• The rash typically begins on ankles, wrists, or forearms 2-4 days after fever onset, then spreads to palms, soles, arms, legs, and trunk 1
• Critical pitfall: <50% of patients have a rash in the first 3 days, and some never develop a rash—absence of rash should not preclude consideration 1
• Laboratory findings include thrombocytopenia, hyponatremia, and increased hepatic transaminases 1
• Immediate empiric doxycycline treatment is essential when RMSF is suspected, as delays in diagnosis increase mortality 1

Rickettsia parkeri Rickettsiosis

• Presents with eschar, sparse maculopapular or vesiculopapular rash that may involve palms and soles 1
• Associated with fever, myalgia, and headache with 2-10 day incubation period 1

Common Dermatologic Conditions

Palmoplantar Psoriasis

• Presents as erythematous, scaly, fissured hyperkeratotic patches and plaques on palmar surfaces 2
• Can be severely debilitating despite affecting small body surface area, causing significant pain and functional impairment 2
• May occur with or without psoriasis elsewhere on the body 3

Treatment algorithm for palmoplantar psoriasis:

1. First-line: High-potency topical corticosteroids (e.g., clobetasol) under occlusion 2
2. Second-line: Acitretin 25 mg daily, which often shows substantial improvement within 2 months 2
3. Third-line: Topical PUVA (soak PUVA) 2-3 times weekly for several months 2
4. Fourth-line: Systemic therapies including methotrexate, cyclosporine, or biologics (adalimumab, infliximab, anti-IL-17A, anti-IL-23 agents) 2
5. Combination therapy: Acitretin with topical PUVA reduces treatment sessions and potentially decreases malignancy risk 2

Palmoplantar Pustulosis (PPP)

• Characterized by sterile, erupting pustules on palms and/or soles, often debilitating and treatment-resistant 4
• Strongly associated with smoking and upper respiratory infections 4
• Best treatment option is acitretin, especially in combination with PUVA 4
• Newer targeted therapies include anti-IL-17A, anti-IL-23, and IL-36 receptor blockers (spesolimab, ANB019) 4

Contact Dermatitis (Allergic and Irritant)

Allergic Contact Dermatitis (ACD):

• All patients with hand dermatitis persisting >3 months should undergo patch testing to identify contact allergens 5, 6
• Common allergens include nickel (14.5%), fragrances (37%), cobalt (22%), and p-phenylenediamine 5
• Treatment requires identification and strict avoidance of allergens, plus topical corticosteroids for flares 7
• For glove-related ACD, use accelerator-free gloves (rubber-free neoprene or nitrile) 7

Irritant Contact Dermatitis (ICD):

• Results from repetitive exposure to irritants including frequent handwashing, detergents, soaps, and sanitizers 7, 5
• Risk factors include wet work, washing with hot/cold water, use of disinfectant wipes, and working with bleach 7
• Treatment approach: identify and avoid irritants, apply moisturizer after each handwashing (two fingertip units), and use barrier creams 7
• "Soak and smear" technique: soak hands in plain water for 20 minutes, then immediately apply moisturizer to damp skin nightly for up to 2 weeks 7
• Topical corticosteroids only if conservative measures fail 7

Pompholyx (Dyshidrotic Eczema)

• Vesicobullous disorder of palms and soles with characteristic dew-drop-like vesicles 8
• Treatment: topical corticosteroids as cornerstone, with calcineurin inhibitors as alternative 8
• For severe cases: topical PUVA with methoxsalen, systemic corticosteroids, or alitretinoin 8
• Intradermal botulinum toxin is an evolving treatment option 8

Important Differential Considerations

Ehrlichiosis

• Rash occurs in approximately 30% of adults and 60% of children, may involve palms and soles 1
• Appears median of 5 days after illness onset with fever, headache, malaise 1
• Laboratory findings: leukopenia, thrombocytopenia, increased hepatic transaminases 1

Mycosis Fungoides Palmaris et Plantaris (MFPP)

• Rare cutaneous T-cell lymphoma variant that mimics dyshidrotic eczema 9
• Critical pitfall: often misdiagnosed as eczema; consider when lesions persist despite topical corticosteroid treatment 9
• Requires biopsy for diagnosis and oncology referral 9

Drug-Induced (Hand-Foot Syndrome)

• Capecitabine and other chemotherapy agents can cause painful palmoplantar erythrodysesthesia 10
• Management requires dose reduction or temporary cessation of offending agent 10

Diagnostic Approach

Essential history elements:

• Timing and pattern of rash onset (acute vs. chronic) 5, 6
• Occupational and recreational exposures to irritants and allergens 5, 6
• Recent tick exposure or outdoor activities (for rickettsial diseases) 1
• Systemic symptoms: fever, headache, myalgia 1
• Personal/family history of atopy or psoriasis 11, 3, 5
• Medication history, especially chemotherapy 10
• Smoking history (for PPP) 4

Physical examination priorities:

• Assess for systemic signs of infection (fever, lymphadenopathy) 1
• Examine for rash elsewhere on body, eschars, or nail changes 11, 1, 3
• Document morphology: vesicular, pustular, maculopapular, hyperkeratotic, or petechial 1, 4, 8
• Check for fissuring, scaling, and functional impairment 2

Laboratory and diagnostic testing:

• If febrile with palmar rash: CBC with differential, hepatic transaminases, electrolytes to evaluate for RMSF 1
• Patch testing for chronic hand dermatitis (>3 months duration) 5, 6
• Skin biopsy if atypical presentation or treatment-resistant 9